Literature DB >> 3299706

Severely impaired adipsin expression in genetic and acquired obesity.

J S Flier, K S Cook, P Usher, B M Spiegelman.   

Abstract

Adipsin, a serine protease homolog, is synthesized and secreted by adipose cells and is found in the bloodstream. The expression of adipsin messenger RNA (mRNA) and protein was analyzed in rodents during metabolic perturbations and in several experimental models of obesity. Adipsin mRNA abundance is increased in adipose tissue during fasting in normal rats and in diabetes due to streptozotocin-induced insulin deficiency. Adipsin mRNA abundance decreased during the continuous infusion of glucose, which induces a hyperglycemic, hyperinsulinemic state that is accompanied by an increased adipose mass; it is suppressed (greater than 100-fold) in two strains of genetically obese mice (db/db and ob/ob), compared to their congenic counterparts, and is also reduced when obesity is induced chemically by injection of monosodium glutamate into newborn mice. Circulating adipsin protein is decreased in these animal models of obesity, as determined by immunoblotting with antisera to adipsin. Little change in adipsin expression is observed in a model of obesity obtained by pure overfeeding of normal rats (cafeteria model). These data suggest a possible role for adipsin in the above-mentioned disordered metabolic states, and raise the possibility that adipsin expression may be used to distinguish obesities that arise from certain genetic or metabolic defects from those that result from pure overfeeding.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299706     DOI: 10.1126/science.3299706

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  72 in total

Review 1.  Molecular events regulating messenger RNA stability in eukaryotes.

Authors:  K S Saini; I C Summerhayes; P Thomas
Journal:  Mol Cell Biochem       Date:  1990-07-17       Impact factor: 3.396

Review 2.  Appetite and energy balance signals from adipocytes.

Authors:  Paul Trayhurn; Chen Bing
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 3.  Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes.

Authors:  Olusola Olalekan Elekofehinti; Idowu Olaposi Omotuyi; Jean Paul Kamdem; Oluwamodupe Cecilia Ejelonu; Guimarae Vanessa Alves; Isaac Gbadura Adanlawo; João Batista Teixeira Rocha
Journal:  J Physiol Biochem       Date:  2014-02-25       Impact factor: 4.158

Review 4.  Adipocyte dysfunction, inflammation and metabolic syndrome.

Authors:  Nora Klöting; Matthias Blüher
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 5.  Growth hormone, 1988.

Authors:  M O Thorner; M L Vance
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 6.  Therapeutic dilemmas in type II diabetes mellitus--improving and maintaining beta-cell and insulin sensitivity.

Authors:  J H Karam
Journal:  West J Med       Date:  1988-06

7.  Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.

Authors:  Carrie M Nielson; Jack Wiedrick; Jian Shen; Jon Jacobs; Erin S Baker; Aaron Baraff; Paul Piehowski; Christine G Lee; Arie Baratt; Vladislav Petyuk; Shannon McWeeney; Jeong Youn Lim; Douglas C Bauer; Nancy E Lane; Peggy M Cawthon; Richard D Smith; Jodi Lapidus; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2017-04-06       Impact factor: 6.741

8.  Adipsin is an adipokine that improves β cell function in diabetes.

Authors:  James C Lo; Sanda Ljubicic; Barbara Leibiger; Matthias Kern; Ingo B Leibiger; Tilo Moede; Molly E Kelly; Diti Chatterjee Bhowmick; Incoronata Murano; Paul Cohen; Alexander S Banks; Melin J Khandekar; Arne Dietrich; Jeffrey S Flier; Saverio Cinti; Matthias Blüher; Nika N Danial; Per-Olof Berggren; Bruce M Spiegelman
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

9.  ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis.

Authors:  Sokrates Stein; Christine Lohmann; Christoph Handschin; Elin Stenfeldt; Jan Borén; Thomas F Lüscher; Christian M Matter
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

10.  Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

Authors:  Jang Hyun Choi; Alexander S Banks; Jennifer L Estall; Shingo Kajimura; Pontus Boström; Dina Laznik; Jorge L Ruas; Michael J Chalmers; Theodore M Kamenecka; Matthias Blüher; Patrick R Griffin; Bruce M Spiegelman
Journal:  Nature       Date:  2010-07-22       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.